Irene M. Hramiak
MD, FRCP(C), FACP
Dr. Hramiak, MD, FRCP(C), FACP is a Professor of Medicine, University of Western Ontario, London, ON. She is the Chair of the Division of Endocrinology and Metabolism at the University of Western Ontario.
Dr. Hramiak practices at St. Joseph’s Health Care London in London, Ontario. She has a strong clinical interest in diabetes. She has been the Medical Director of the Diabetes Education Center of St. Joseph’s Health Care since 2000.
Dr. Hramiak has held peer reviewed funding from JDRF, CDA, and the NIH. Dr. Hramiak was a co-investigator in the DCCT – a major outcome trial in Type 1 diabetes mellitus. As a DCCT investigator, she was awarded the Charles H. Best Award for distinguished service by the American Diabetes Association in 1993. She was a Principal Investigator in the ACCORD and ORIGIN trials, which assessed cardiac outcomes in patients with Type 2 diabetes mellitus. Dr. Hramiak is the Principal Investigator at Western University for the JDRF Ontario Clinical Trial Network. She is the Principal Investigator for the REMOVAL trial, which is assessing macrovascular complications in Type 1 diabetes. She is the Principal Investigator in Ontario for the JDRF-sponsored artificial pancreas program.
In addition, she has been involved in many clinical trials assessing new treatment strategies in both Type 1 and Type 2 diabetes mellitus, and obesity. She serves as an external advisor to many groups and pharmaceutical companies with regards to diabetes and obesity.